Darren SissonsBavarian Nordic A/SBVNRYDON'T BUYJul 20, 2022
Small vaccine company, niche-oriented. Covid beneficiary. The issue is that it relies on a number of smaller opportunities. He prefers bigger companies with more diversification. Better opportunities in the space.